Ticker Update
Curis, Inc. (CRIS) Skyrocketed up to 450% on Tuesday After Positive Phase 1 Results of leukemia Study
The small-cap biotech has reported positive data from phase 1 trials of CA-4948. Curis has also announced its public offering for the common stock. Curis, Inc. (CRIS) is all bullish following the release of positive preliminary data of its Phase 1 trials of CA-4948. The
